Comparison tool
Compare peptides
Pick up to three compounds. Useful for deciding whether two peptides in a stack actually do different things, or whether you're paying twice for the same pathway.
Select up to three (1/3)
| Attribute | |
|---|---|
| Category | Cognitive |
| Evidence grade | Limited |
| Also known as | Tuftsin analogue, TP-7 |
| Mechanism | A synthetic analogue of the immunopeptide tuftsin. It modulates GABA-A expression, inhibits enkephalin degradation and shifts the balance of monoamine neurotransmitters, producing calm without benzodiazepine-like sedation. |
| Key benefits | Anxiolytic effect without sedation or dependence · Improved stress resilience · Mild cognitive and immune modulation |
| Side effects | Nasal irritation · Occasional drowsiness · Rare mood flattening |
| Half-life | Short — dosed 1–3 times daily |
| Administration | Intranasal spray |
| Dosing overview | 250–750 mcg daily in divided doses, 2–4 week cycles |
| Storage | Refrigerated solution, protected from light |
| Legal status | Registered in Russia; research-only status elsewhere. |
Dosing figures reflect published literature and commonly reported community protocols. They are informational only.